(Q45750467)

15 December 2017

title

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease (English)

1 reference

15 December 2017

1 reference

chronic liver disease

0 references

1 reference

6

1 reference

15 December 2017

author name string

M Asti

1

1 reference

15 December 2017

M Martinetti

2

1 reference

15 December 2017

C Zavaglia

3

1 reference

15 December 2017

M C Cuccia

4

1 reference

15 December 2017

L Gusberti

5

1 reference

15 December 2017

A Cividini

7

1 reference

15 December 2017

S Bruno

8

1 reference

15 December 2017

L Salvaneschi

9

1 reference

15 December 2017

G Ideo

10

1 reference

15 December 2017

M U Mondelli

11

1 reference

15 December 2017

E M Silini

12

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

29

1 reference

15 December 2017

page(s)

1272-1279

1 reference

15 December 2017

issue

4

1 reference

15 December 2017

Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Is there a role for immune responses in the pathogenesis of hepatitis C?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

A biological role for the major histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

HLA typing in chronic type B, D and C hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Immunologic features and HLA associations in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Allelic variants of the human putative peptide transporter involved in antigen processing

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Peptide size selection by the major histocompatibility complex-encoded peptide transporter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-a and TNF-0 by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Inherited structural polymorphism of the fourth component of human complement

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Genetic polymorphism in human glycine-rich beta-glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Revised nomenclature for human complement component C4. WHO-IUIS Nomenclature Sub-Committee

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Correspondence analysis in medical research

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Critical role of Val/Gly86 HLA-DRB dimorphism in the neonatal resistance or susceptibility to maternal hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

T-cell activation in HLA-B8,DR3-positive individuals early antigen expression defect in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Natural killer and lymphokine-activated killer activity in HLA-B8,DR3-positive subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Immunological aspects of HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Population dynamics of immune responses to persistent viruses.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Immunogenetics in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Reverse immunogenetics: from HLA-disease associations to vaccine candidates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290445

7 January 2021

Identifiers

DOI

10.1002/HEP.510290445

1 reference

15 December 2017

PubMed ID

10094975

1 reference

15 December 2017